S. PEHLİVAN Et Al. , "Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients," JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4, pp.495-505, 2020
PEHLİVAN, S. Et Al. 2020. Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients. JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4 , 495-505.
PEHLİVAN, S., Aytac, H. M., Kurnaz, S., Pehlivan, M., & Aydin, P. C., (2020). Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients. JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4, 495-505.
PEHLİVAN, Sacide Et Al. "Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients," JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4, 495-505, 2020
PEHLİVAN, Sacide Et Al. "Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients." JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4, pp.495-505, 2020
PEHLİVAN, S. Et Al. (2020) . "Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients." JOURNAL OF ADDICTIVE DISEASES , vol.38, no.4, pp.495-505.
@article{article, author={Sacide PEHLİVAN Et Al. }, title={Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients}, journal={JOURNAL OF ADDICTIVE DISEASES}, year=2020, pages={495-505} }